Every time an AI alert is sent,Zhenghai Biological (SZ 300653, closing price: 64.78 yuan) released the first quarter results announcement on the evening of April 14, saying that the revenue in the first quarter of 2022 will be about 118 million yuan, a year-on-year increase of 15.28%; the net profit will be about 55.02 million yuan, a year-on-year increase. 25.07%; basic earnings per share were 0.46 yuan, a year-on-year increase of 24.32%.
The chairman of Zhenghai Biological is Wang Tao, male, 43 years old, with a master’s degree; the general manager is Sha Shuzhuang, male, 42 years old, with a bachelor’s degree.
1. In the past 30 days, Zhenghai Biological’s northbound capital holdings decreased by 237,400 shares, accounting for a 0.19% decrease in the proportion of tradable shares;
2. In the past 30 days, no institution has conducted research on Zhenghai Biological.
(Reporter Cai Ding)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Do so at your own risk.
Copyright Notice
1This article is an original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, excerpting, copying or creating mirror images, etc. Violators will be held accountable.
3Copyright cooperation telephone: 021-60900099.